The pharmaceutical packaging industry in the US is crucial for ensuring the safe delivery of medications. Companies in this sector create a wide array of packaging solutions, from blister packs to temperature-controlled containers, tailored to meet the unique needs of pharmaceuticals. With the rise of biologics and personalized medicine, there is a growing demand for innovative packaging designed to protect sensitive products. Sustainability is also on the horizon, as more companies seek eco-friendly materials. As technological advancements continue, the packaging landscape evolves, integrating smart features to enhance functionality and compliance.


This article highlights 19 notable investors in pharmaceutical packaging, showcasing a mix of venture capital, private equity, and corporate firms. Together, these sponsors have headquarters in key cities such as New York, Palo Alto, and Seattle. Founded between the late 1940s and the early 2000s, these investors collectively engaged in 2024 transactions spanning diverse deal sizes and strategies. Noteworthy is Y Combinator's 802 investments, demonstrating the significant role these investors play in shaping the pharmaceutical packaging landscape.


Top 19 Pharmaceutical Packaging Investors in the US


1. Y Combinator

  • Website: ycombinator.com
  • Type: Venture Capital
  • Headquarters: San Francisco, California, United States (USA)
  • Founded year: 2005
  • Headcount: 51-200
  • Number of deals in 2024: 802
  • LinkedIn: y-combinator

Y Combinator is a prominent startup accelerator and venture capital firm based in San Francisco, California, founded in 2005. It provides funding and mentorship to early-stage technology companies through a structured program that aids entrepreneurs in launching and growing their businesses. Y Combinator has successfully launched over 4,000 startups, making it a key player in the technology startup ecosystem. Among its diverse investments, Y Combinator has funded Georgette Packaging, which raised $120,000 in a Pre-Seed round in March 2016, indicating its engagement in the packaging sector. Additionally, it has invested in Intact Therapeutics, which raised $150,000 in a Pre-Seed round in March 2019, further showcasing its involvement in the pharmaceutical industry. These transactions highlight Y Combinator's potential relevance to the pharmaceutical packaging sector, despite its broader focus on technology startups.


2. New Enterprise Associates (NEA)

  • Website: nea.com
  • Type: Venture Capital
  • Headquarters: Menlo Park, California, United States (USA)
  • Founded year: 1977
  • Headcount: 51-200
  • Number of deals in 2024: 57
  • LinkedIn: new-enterprise-associates

New Enterprise Associates (NEA) is a prominent venture capital firm based in Menlo Park, California, founded in 1977. NEA specializes in investment management and advisory services for startups, particularly in the technology and healthcare sectors. The firm partners with entrepreneurs to provide funding and strategic guidance, helping them navigate the challenges of building successful businesses. NEA operates through a collaborative approach, emphasizing long-term relationships with founders. Notably, NEA has participated in significant funding rounds for companies like Novast Pharmaceuticals, which raised $25 million in Series C funding, and Spyglass Pharma, which raised $90 million in Series C funding to support clinical trials of its drug delivery platform. These transactions highlight NEA's involvement in the pharmaceutical industry, particularly in areas that may relate to pharmaceutical packaging and drug delivery systems.


3. Perceptive Advisors


Perceptive Advisors is a New York-based venture capital firm founded in 1999, specializing in the life sciences sector. The firm provides capital solutions and investment management services to both private and public healthcare companies, with a focus on biotechnology, pharmaceuticals, and medical devices. Their expertise aids clients in securing funding for innovation and growth within the healthcare industry. Notable transactions include a $16 million seed funding for Surf Bio, which is developing a polymer-based drug delivery platform, and a $11.5 million Series A financing for Vitruvias Therapeutics, aimed at advancing multiple projects in drug development. These investments highlight their engagement in areas that intersect with pharmaceutical packaging, particularly in drug delivery systems and technologies that may require innovative packaging solutions.


4. Frazier Healthcare Partners


Frazier Healthcare Partners is a venture capital investment firm based in Seattle, Washington, specializing in healthcare and life sciences. Founded in 1991, the firm focuses on growth buyout investments in profitable healthcare businesses and innovative biopharmaceuticals. Frazier Healthcare has a diverse portfolio, with notable transactions in the pharmaceutical packaging sector, including the acquisition of Packaging Coordinators, Inc. from Catalent Pharma Solutions in 2012, which allowed them to expand their footprint in pharmaceutical packaging. Additionally, their acquisition of CSafe Global in 2021 highlights their commitment to investing in companies that provide critical packaging solutions for the pharmaceutical industry. Their clients primarily consist of healthcare companies seeking capital to scale operations and enhance service offerings, making them a significant player in the healthcare investment landscape.


5. Vivo Capital

  • Website: vivocapital.com
  • Type: Venture Capital
  • Headquarters: Palo Alto, California, United States (USA)
  • Founded year: 1996
  • Headcount: 51-200
  • Number of deals in 2024: 19
  • LinkedIn: vivo-capital

Vivo Capital is a venture capital firm based in Palo Alto, California, founded in 1996. The firm specializes in healthcare investments, providing venture capital, private equity, and public equity to companies that develop healthcare technologies and products. Vivo Capital has been actively involved in significant transactions within the pharmaceutical sector, including multiple rounds of funding for Sagent Pharmaceuticals, which raised substantial capital to support product launches and development activities. Additionally, Vivo Capital acquired Serán Bioscience, a contract development and manufacturing organization, indicating their commitment to companies that play a role in the pharmaceutical supply chain, including packaging. With 19 investments in 2024 alone, Vivo Capital continues to facilitate innovation and growth in the healthcare sector, making them a relevant player in the pharmaceutical packaging industry.


6. Janus Henderson Investors

  • Website: janushenderson.com
  • Type: Private Equity
  • Headquarters: Denver, Colorado, United States (USA)
  • Founded year: 2017
  • Headcount: 1001-5000
  • Number of deals in 2024: 39
  • LinkedIn: janus-henderson-emea

Janus Henderson Investors is an asset management firm founded in 2017, headquartered in Denver, Colorado, and operates globally from its London office. The firm provides a range of investment products, including ETFs, mutual funds, and managed accounts, aimed at individual investors, financial professionals, and institutional clients. In 2024, Janus Henderson has been involved in 39 investments, showcasing their active role in the market. Notably, they participated in significant funding rounds for biotechnology companies such as Elektrofi, which raised $112.25 million in Series C financing to develop drug formulation and delivery systems, and $40 million in Series B financing to establish Good Manufacturing Practice (GMP) capabilities. These transactions highlight their engagement in areas that intersect with pharmaceutical packaging, as effective drug delivery systems are crucial for the packaging industry. Additionally, their involvement in other biotech firms like VelosBio and BioTheryx further emphasizes their focus on advancing pharmaceutical innovations, which often require sophisticated packaging solutions.


7. Silicon Valley Bank

  • Website: svb.com
  • Type: Venture Capital
  • Headquarters: Santa Clara, California, United States (USA)
  • Founded year: 1983
  • Headcount: 5001-10000
  • Number of deals in 2024: 31
  • LinkedIn: silicon-valley-bank

Silicon Valley Bank is a commercial bank founded in 1983, specializing in providing financial services to the innovation economy, particularly tech startups and venture capital firms. With a focus on business banking, global payments, and asset management, they help clients navigate financial challenges and support their growth. Notably, Silicon Valley Bank has been involved in several transactions relevant to the pharmaceutical sector, including significant debt financing for QuVa Pharma, which has raised over $200 million in total capital, indicating their commitment to supporting pharmaceutical manufacturing and packaging solutions. Additionally, they have provided funding to Eyenovia, a company involved in the pharmaceutical industry, further demonstrating their engagement in this field.


8. Deep Tech Fund (an Alumni Ventures Fund)

  • Website: av.vc
  • Type: Venture Capital
  • Headquarters: Manchester, New Hampshire, United States (USA)
  • Founded year: 2023
  • Headcount: 51-200
  • Number of deals in 2024: 258
  • LinkedIn: deep-tech-fund-av-focused-fund

The Deep Tech Fund (an Alumni Ventures Fund) is a venture capital firm based in Manchester, New Hampshire, founded in 2023. It provides accredited investors and institutions with access to professionally-managed, diversified venture portfolios, leveraging a network of over 10,000 investors to connect them with high-quality investment opportunities in the startup ecosystem. Notably, the fund has participated in transactions involving companies like Tipa, which specializes in compostable flexible packaging solutions, and Loliware, which focuses on seaweed-based materials. These investments reflect a commitment to innovative packaging solutions that could have applications in various industries, including pharmaceuticals, as sustainability becomes a key consideration in packaging design.


9. Polaris Partners

  • Website: polarispartners.com
  • Type: Venture Capital
  • Headquarters: Boston, Massachusetts, United States (USA)
  • Founded year: 1996
  • Headcount: 11-50
  • Number of deals in 2024: 19
  • LinkedIn: polaris-partners

Polaris Partners is a venture capital firm based in Boston, Massachusetts, founded in 1996. The firm specializes in healthcare and biotechnology investments, partnering with entrepreneurs to provide funding and strategic guidance to help them innovate and grow their businesses. Polaris has a diverse portfolio that includes companies focused on transformative healthcare solutions. Notably, they participated in funding rounds for August Bioservices, a Contract Development and Manufacturing Organization, which raised significant capital in both Series A and Series B funding. This involvement highlights their interest in companies that are integral to the pharmaceutical supply chain, including aspects related to pharmaceutical packaging. Additionally, their investments in biotech firms like Avitide further demonstrate their commitment to supporting companies that may require advanced packaging solutions for their products.


10. Advantage Capital


Advantage Capital is a venture capital firm based in New Orleans, Louisiana, founded in 1992. The firm specializes in providing equity and debt financing to small businesses across various sectors, including agribusiness, solar projects, and affordable housing. They focus on supporting entrepreneurs and businesses in underserved communities, offering flexible capital solutions to help them grow and thrive. Notably, Advantage Capital has been involved in transactions relevant to the pharmaceutical industry, such as CapzerPharma Manufacturing, which raised debt financing in December 2018, and IPAK, which secured both debt and Series A financing in March 2017. These transactions highlight their engagement with companies that operate in the pharmaceutical space, suggesting a potential interest in pharmaceutical packaging as part of their investment portfolio.


11. GV (Google Ventures)

  • Website: gv.com
  • Type: Venture Capital
  • Headquarters: San Francisco Bay Area, California, United States (USA)
  • Founded year: 2009
  • Headcount: 51-200
  • Number of deals in 2024: 74
  • LinkedIn: gv

GV (Google Ventures) is a venture capital firm founded in 2009, based in the San Francisco Bay Area, California. With over $10 billion in assets under management, GV focuses on various sectors, including life sciences and artificial intelligence. The firm partners with founders to help them navigate the challenges of building successful companies. Notably, GV has invested in Rani Therapeutics, a company that is developing the RaniPill, an innovative oral drug delivery system. This investment aligns with the pharmaceutical packaging industry, as it involves creating manufacturing infrastructure for clinical trials and enhancing drug delivery methods. GV's participation in multiple funding rounds for Rani Therapeutics, including Series C and Series D, highlights their commitment to supporting advancements in life sciences that could impact pharmaceutical packaging.


12. F-Prime


F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, founded in 1946. The firm specializes in creating and investing in healthcare and technology companies, providing both venture capital investments and advisory services to entrepreneurs. F-Prime has a global presence and expertise that enables them to support start-ups effectively. Notably, they have participated in significant funding rounds for companies like TraceLink, which raised substantial amounts in Series C and D funding to enhance the digitalization of the global pharmaceutical supply chain. This involvement highlights their commitment to advancing healthcare solutions, including those related to pharmaceutical packaging.


13. Invus

  • Website: invus.com
  • Type: Venture Capital
  • Headquarters: New York, New York, United States (USA)
  • Founded year: 1985
  • Headcount: 51-200
  • Number of deals in 2024: 35
  • LinkedIn: invus

Invus is a venture capital firm based in New York, specializing in equity investments and investment management since its founding in 1985. The firm partners with owner-managers across various industries to enhance business performance and create sustainable value. Invus has been involved in several notable transactions in the pharmaceutical sector, including Lyndra Therapeutics, which focuses on innovative drug delivery systems, and Oyster Point Pharmaceuticals, which develops treatments for Dry Eye Disease. These investments highlight Invus's commitment to supporting companies that may require advanced pharmaceutical packaging solutions to deliver their products effectively. With a focus on long-term growth, Invus leverages its expertise to navigate complex investment landscapes, making it a significant player in the pharmaceutical investment arena.


14. The Riverside Company


The Riverside Company is a private equity investment firm founded in 1988, based in New York, New York. It specializes in providing flexible capital solutions and focuses on smaller middle-market businesses across various industries. Riverside manages a diverse portfolio of over 140 companies globally. Notably, they have made significant acquisitions in the packaging sector, including the acquisition of Selig Group in 2002 and Vitex Packaging Group in 1998. These transactions highlight their strategic interest in the packaging industry, which is closely related to pharmaceutical packaging, as these companies provide essential packaging solutions that can be utilized in the pharmaceutical sector. Additionally, Riverside's acquisition of Maverick Enterprise, Inc. further demonstrates their engagement in the broader packaging market.


15. Oxford Finance LLC

  • Website: oxfordfinance.com
  • Type: Corporate
  • Headquarters: Alexandria, Virginia, United States (USA)
  • Founded year: 2002
  • Headcount: 51-200
  • Number of deals in 2024: 2
  • LinkedIn: oxford-finance-llc

Oxford Finance LLC is a corporate investor based in Alexandria, Virginia, founded in 2002. The firm specializes in providing flexible lending solutions to middle-market companies primarily in the life sciences and healthcare sectors. They offer a variety of financial products, including enterprise lending, leveraged lending, and real estate financing, aimed at helping businesses secure the necessary capital for growth and innovation. Notably, Oxford Finance has been involved in significant transactions within the pharmaceutical sector, such as providing debt funding to QuVa Pharma, which raised over $200 million, and Enable Injections, which secured a $25 million credit facility to support high-volume manufacturing. Other relevant transactions include funding for Acura Pharmaceuticals, Antheia, and Halozyme Therapeutics, all of which are connected to the pharmaceutical industry, further emphasizing Oxford Finance's role in supporting companies that contribute to pharmaceutical packaging and delivery.


16. Kkr

  • Website: kkr.com
  • Type: Private Equity
  • Headquarters: New York, New York, United States (USA)
  • Founded year: 1976
  • Headcount: 1001-5000
  • Number of deals in 2024: 74
  • LinkedIn: kkr

KKR & Co. Inc. is a prominent investment firm based in New York, specializing in private equity, credit, infrastructure, and real estate. Founded in 1976, KKR provides asset management solutions to institutional investors and individual clients, helping them navigate complex investment landscapes and achieve strong financial returns. KKR operates globally, leveraging its extensive expertise and resources to support its clients' investment needs. Among its notable transactions, KKR acquired a 70% stake in CMC Machinery, an Italian leader in automated packaging solutions, for approximately $1.3 billion, marking a significant entry into the pharmaceutical packaging sector. Additionally, KKR's acquisition of Bushu Pharma for $769 million and a 54% stake in JB Chemicals & Pharma for $416 million further solidify its presence in the pharmaceutical industry, which often requires specialized packaging solutions. KKR's investment in Petainer, a UK packaging company, also reflects its strategic interest in the packaging domain.


17. Blackstone

  • Website: blackstone.com
  • Type: Private Equity
  • Headquarters: New York, New York, United States (USA)
  • Founded year: 1985
  • Headcount: 1001-5000
  • Number of deals in 2024: 57
  • LinkedIn: blackstonegroup

Blackstone Inc. is a prominent investment management firm based in New York, specializing in alternative investments across various sectors, including private equity, real estate, and credit solutions. Founded in 1985, Blackstone has built a reputation for its strategic investments and ability to enhance business value. Among its notable transactions in the pharmaceutical packaging context, Blackstone acquired Gerresheimer Glas, a key player in the packaging industry, in 2004, and more recently, it secured a majority stake in Essel Propack for up to $460 million in 2019. These investments highlight Blackstone's commitment to the pharmaceutical packaging sector, alongside its broader investment strategies.


18. The Carlyle Group

  • Website: carlyle.com
  • Type: Private Equity
  • Headquarters: Washington, D.C., District Of Columbia, United States (USA)
  • Founded year: 1987
  • Headcount: 1001-5000
  • Number of deals in 2024: 25
  • LinkedIn: the-carlyle-group

The Carlyle Group Inc. is a prominent investment management firm founded in 1987, specializing in private equity, real assets, and private credit. With a global presence and a workforce of 1001-5000 employees, Carlyle serves institutional investors, including pension funds and sovereign wealth funds, by providing tailored investment solutions and access to alternative asset classes. Notably, Carlyle has made significant investments in the pharmaceutical packaging sector, including the acquisition of HCP Packaging in May 2022, which underscores their commitment to this industry. Additionally, their acquisition of Albany Molecular Research in June 2017 and a minority stake in Logoplaste in June 2016 further highlight their engagement in sectors related to pharmaceuticals and packaging. These transactions reflect Carlyle's strategy to drive long-term value for its clients while diversifying its investment portfolio across various industries.


19. Venrock

  • Website: venrock.com
  • Type: Venture Capital
  • Headquarters: Palo Alto, California, United States (USA)
  • Founded year: 1969
  • Headcount: 51-200
  • Number of deals in 2024: 11
  • LinkedIn: venrock

Venrock is a venture capital firm founded in 1969 and based in Palo Alto, California. The firm has a strong focus on healthcare, technology, and life sciences. They have made significant investments in various healthcare companies, including RelayHealth, which raised multiple rounds of funding from Venrock, indicating their commitment to healthcare technology solutions. Additionally, their investment in Centocor Ortho Biotech highlights their involvement in the pharmaceutical sector. Venrock aims to improve the health and well-being of individuals through innovative solutions, which may include advancements in pharmaceutical packaging as part of their broader healthcare investment strategy.



Pharmaceutical Packaging Insights: Key Investors in the US


InvestorHeadquarterSizeFoundedDeals 2024
Y CombinatorSan Francisco, California, United States (USA)51-2002005802
New Enterprise Associates (NEA)Menlo Park, California, United States (USA)51-200197757
Perceptive AdvisorsNew York, New York, United States (USA)11-50199945
Frazier Healthcare PartnersSeattle, Washington, United States (USA)51-200199127
Vivo CapitalPalo Alto, California, United States (USA)51-200199619
Janus Henderson InvestorsDenver, Colorado, United States (USA)1001-5000201739
Silicon Valley BankSanta Clara, California, United States (USA)5001-10000198331
Deep Tech Fund (an Alumni Ventures Fund)Manchester, New Hampshire, United States (USA)51-2002023258
Polaris PartnersBoston, Massachusetts, United States (USA)11-50199619
Advantage CapitalNew Orleans, Louisiana, United States (USA)51-20019925
GV (Google Ventures)San Francisco Bay Area, California, United States (USA)51-200200974
F-PrimeCambridge, Massachusetts, United States (USA)11-50194639
InvusNew York, New York, United States (USA)51-200198535
The Riverside CompanyNew York, New York, United States (USA)201-500198812
Oxford Finance LLCAlexandria, Virginia, United States (USA)51-20020022
KkrNew York, New York, United States (USA)1001-5000197674
BlackstoneNew York, New York, United States (USA)1001-5000198557
The Carlyle GroupWashington, D.C., District Of Columbia, United States (USA)1001-5000198725
VenrockPalo Alto, California, United States (USA)51-200196911


Want to find more investors focusing on the pharmaceutical packaging industry?

If you want to find more investors that are active in the pharmaceutical packagingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!